Structure Therapeutics Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | -886.1% | – | |
| – | -8.9% | +208.3% | +4.5% | +14.2% | +3.0% | +0.4% | +6.2% | +22.3% | +15.7% | +39.8% | -4.3% | – | |
| – | +12.9% | +30.8% | +52.9% | +43.5% | -3.2% | +1.5% | +26.9% | -0.2% | +7.7% | +44.2% | +8.5% | – | |
| – | -1.2% | -400.3% | – | – | -103.9% | – | – | +208.5% | -1,089.0% | – | -134.0% | – | |
| – | +41.0% | -86.0% | +163.6% | +60.4% | -97.7% | +1,862.5% | -26.1% | +577.6% | -4.8% | -20.8% | -96.5% | – | |
| – | -699.9% | – | -14,522.8% | -7.6% | – | +2.4% | +43.8% | -200.8% | – | -987.8% | – | – | |
| – | +59,441.0% | -99.8% | +73,219.5% | -100.1% | – | +31.5% | -36.1% | +10,771.0% | +1,154.4% | -100.2% | – | – | |
| – | +688.0% | -140.4% | – | -173.8% | – | – | – | – | – | -169.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -952.0% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.